GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

Winkler, Ethan A, Nishida, Yoichiro, Sagare, Abhay P, Rege, Sanket V, Bell, Robert D, Perlmutter, David, Sengillo, Jesse D, Hillman, Sara +12 more·2015·Nature Neuroscience

Cited by (682)

Items 201–300 of 682

  1. MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1
    Wenjing Liu, Heng Cai, Meiqing Lin, Lu Zhu, Lili Gao, Renjia Zhong, Siwei Bi, Yixue Xue, Xiuli Shang · 2016 · Experimental Cell Research
  2. Aging related impairment of brain microvascular bioenergetics involves oxidative phosphorylation and glycolytic pathways
    Siva S. V. P. Sakamuri, Venkata N. L. R. Sure, Lahari Kolli, Wesley R Evans, Jared A Sperling, Gregory Jaye Bix, Xiaoying Wang, Dmitriy N Atochin, Walter L Murfee, Ricardo Mostany et al. · 2022 · Journal of Cerebral Blood Flow & Metabolism
  3. Stroke-induced damage on the blood–brain barrier
    Song Xue, Xin Zhou, Zhihui Yang, Xiang‐Kun Si, Xin Sun · 2023 · Frontiers in Neurology
  4. The effect of aging on brain barriers and the consequences for Alzheimer’s disease development
    Nina Gorlé, Caroline Van Cauwenberghe, Claude Libert, Roosmarijn E. Vandenbroucke · 2016 · Mammalian Genome
  5. Re-engineering therapeutic antibodies for Alzheimer’s disease as blood-brain barrier penetrating bi-specific antibodies
    William M. Pardridge · 2016 · Expert Opinion on Biological Therapy
  6. Diabetes‐induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain
    Nikita Ved, Marlene E. Da Vitoria Lobo, Samuel M. Bestall, C. L. Vidueira, Nicholas Beazley‐Long, Kurt Ballmer‐Hofer, Masanori Hirashima, David O. Bates, Lucy Frances Donaldson, Richard P. Hulse · 2018 · The Journal of Physiology
  7. Exercise, Arterial Stiffness, and Cerebral Vascular Function: Potential Impact on Brain Health
    Jill Nicole Barnes, Andrew G. Pearson, Adam T. Corkery, Nicole A. Eisenmann, Kathleen B. Miller · 2021 · Journal of the International Neuropsychological Society
  8. Impact of intestinal disorders on central and peripheral nervous system diseases
    Yumna El-Hakim, Shameena Bake, Kathiresh Kumar Mani, Farida Sohrabji · 2022 · Neurobiology of Disease
  9. The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment
    Allison Bethanne Reiss, Saba Ahmed, Christopher Dayaramani, Amy D. Glass, Irving H. Gomolin, Aaron Pinkhasov, Mark M. Stecker, Thomas Wısnıewskı, Joshua De Leon · 2022 · Experimental Gerontology
  10. The Blood-Brain Barrier
    Weihong Pan, Abba J. Kastin · 2016 · The Neuroscientist
  11. Neurovascular Ageing and Age-Related Diseases
    Raj N. Kalaria, Yoshiki Hase · 2019 · Sub-cellular biochemistry/Subcellular biochemistry
  12. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer’s disease model mouse
    Jingwei Shang, Toru Yamashita, Feng Tian, Xianghong Li, Xia Liu, Xiaowen Shi, Yumiko Nakano, Keiichiro Tsunoda, Emi Nomura, Ryo Sasaki et al. · 2019 · Brain Research
  13. Regular Exercise Enhances Cognitive Function and Intracephalic GLUT Expression in Alzheimer’s Disease Model Mice
    Ruiqi Pang, Xiaofang Wang, Feifei Pei, Wei-Zeng Zhang, Jiaming Shen, Xiao-Qun Gao, Cheng Chang · 2019 · Journal of Alzheimer's Disease
  14. Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease
    Pamela V. Martino Adami, Celia Quijano, Natalia Magnani, Pablo Galeano, Pablo Evelson, Adriana Cassina, Sonia Do Carmo, María Celeste Leal, Eduardo Miguel Castaño, A. Claudio Cuello et al. · 2015 · Journal of Cerebral Blood Flow & Metabolism
  15. The role of neurovascular unit damage in the occurrence and development of Alzheimer’s disease
    Xin Liu, Deren Hou, Fangbo Lin, Jing Luo, Jingwen Xie, Yan Wang, Yi Tian · 2018 · Reviews in the Neurosciences
  16. In vivo imaging and analysis of cerebrovascular hemodynamic responses and tissue oxygenation in the mouse brain
    Kassandra Kisler, Divna Lazić, Melanie D. Sweeney, Shane Plunkett, Mirna El Khatib, Sergei A. Vinogradov, David A. Boas, Sava Sakadžić, Berislav V. Zloković · 2018 · Nature Protocols
  17. Designing peptide nanoparticles for efficient brain delivery
    Aroa Duro‐Castaño, Diana M. Leite, Joe Forth, Yangwei Deng, Diana Matias, Carlos Noble-Jesus, Giuseppe Battaglia · 2020 · Advanced Drug Delivery Reviews
  18. Elevated CLOCK and BMAL1 contribute to the impairment of aerobic glycolysis from astrocytes in Alzheimer's disease
    Yoo, Ik Dong, Park, Min Woo, Cha, Hyeon Woo, Yoon, Sunmi, Boonpraman, Napissara, Yi, Sun Shin, Moon, Jong-Seok · 2020 · International Journal of Molecular Sciences
  19. Environmental lead exposure aggravates the progression of Alzheimer's disease in mice by targeting on blood brain barrier
    Sai Wu, Huaixiang Liu, Heping Zhao, Xiaohui Wang, Jingli Chen, Dong Xia, Xiao Chen, Jianding Cheng, Zhiqiang Zhao, Yun He · 2019 · Toxicology Letters
  20. Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
    Yamir Islam, Andrew G. Leach, Jayden A. Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James R. Downing, Amos A. Fatokun, Meritxell Teixidò, Touraj Ehtezazi · 2021 · Advanced Science
  21. Changes of Blood-Brain Barrier and Brain Parenchymal Protein Expression Levels of Mice under Different Insulin-Resistance Conditions Induced by High-Fat Diet
    Seiryo Ogata, Shingo Ito, Takeshi Masuda, Sumio Ohtsuki · 2019 · Pharmaceutical Research
  22. High-fat diet impairs cognitive function of zebrafish
    Shinichi Meguro, Sayaka Hosoi, Takahiro Hasumura · 2019 · Scientific Reports
  23. Tissue Plasminogen Activator Promotes TXNIP-NLRP3 Inflammasome Activation after Hyperglycemic Stroke in Mice
    Saifudeen Ismael, Sanaz Nasoohi, Arum Yoo, Heba A. Ahmed, Tauheed Ishrat · 2020 · Molecular Neurobiology
  24. Downregulation of the glucose transporter GLUT 1 in the cerebral microvasculature contributes to postoperative neurocognitive disorders in aged mice
    Ying Chen, Jin Deok Joo, John Man Tak Chu, Raymond Chuen‐Chung Chang, Gordon Tin Chun Wong · 2023 · Journal of Neuroinflammation
  25. Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis
    Carlos G. Ardanaz, Aida de la Cruz, Paras Singh Minhas, Nira Hernández‐Martín, Miguel Angel Pozo, M. Pilar Valdecantos, Ángela M. Valverde, Palmira Villa, Marcos Elizalde-Horcada, Elena Puerta et al. · 2024 · Science Advances
  26. Understanding glucose metabolism and insulin action at the blood–brain barrier: Implications for brain health and neurodegenerative diseases
    Yiyi Zhu, Alexei Verkhratsky, Hui Chen, Chenju Yi · 2025 · Acta Physiologica
  27. Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice
    Huazhen Qin, Yu Jiang, Jian Zhang, Chao Deng, Zhiyuan Zhong · 2019 · Molecular Pharmaceutics
  28. Quantitative PET imaging and modeling of molecular blood-brain barrier permeability
    Kevin J. Chung, Yasser G. Abdelhafez, Benjamin A. Spencer, Terry Jones, Tran Nhan Tam Quyen, Lorenzo Nardo, Moon S. Chen, Souvik Sarkar, Valentina Medici, Victoria Lyo et al. · 2025 · Nature Communications
  29. Brain Vascular Imaging Techniques
    Bàrbara Laviña · 2016 · International Journal of Molecular Sciences
  30. Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell‐Derived Brain Endothelial Cells
    Matthew J. Stebbins, Ethan S. Lippmann, Madeline G. Faubion, Richard Daneman, Sean P. Palecek, Eric V. Shusta · 2017 · Biotechnology Journal
  31. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease
    Ana Isabel Duarte, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira · 2018 · Neuropharmacology
  32. The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use.
    M. Shukla, B. Vincent · 2020 · Ageing Research Reviews
  33. Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases
    Debashish Paramanick, Veena Devi Singh, Vijay Kumar Singh · 2022 · Journal of Controlled Release
  34. Near‐critical GLUT1 and Neurodegeneration
    L. Felipe Barros, Alejandro San Martín, Iván Ruminot, Pamela Y. Sandoval, Ignacio Fernández‐Moncada, Felipe Baeza‐Lehnert, Robinson Arce‐Molina, Yasna Contreras‐Baeza, Francisca Cortés‐Molina, Alex Galaz et al. · 2017 · Journal of Neuroscience Research
  35. The LDL Receptor-Related Protein 1: At the Crossroads of Lipoprotein Metabolism and Insulin Signaling
    Dianaly T. Au, Dudley K. Strickland, Selen C. Muratoglu · 2017 · Journal of Diabetes Research
  36. Epigenetics in blood–brain barrier disruption
    Stephanie A. Ihezie, Iny Elizebeth Mathew, Devin William McBride, Ari Dienel, Spiros Blackburn, Peeyush Kumar Thankamani Pandit · 2021 · Fluids and Barriers of the CNS
  37. Astrocyte in Neurological Disease: Pathogenesis and Therapy
    Meihui Huang, Aoyang Long, Lingjia Hao, Zilin Shi, Mengqi Zhang · 2025 · MedComm
  38. Alzheimer’s Disease Phenotype or Inflammatory Insult Does Not Alter Function of L-Type Amino Acid Transporter 1 in Mouse Blood-Brain Barrier and Primary Astrocytes
    Mikko Gynther, Elena Puris, Soile Peltokangas, Seppo O. K. Auriola, Katja M. Kanninen, Jari Koıstınaho, Kristiina M. Huttunen, Marika Ruponen, Kati‐Sisko Vellonen · 2018 · Pharmaceutical Research
  39. Drugs Modulating CD4+ T Cells Blood–Brain Barrier Interaction in Alzheimer’s Disease
    Norwin Kubick, Patrick C. Henckell Flournoy, Ana‐Maria Enciu, Michel‐Edwar Mickael, Gina Manda · 2020 · Pharmaceutics
  40. Cell type-specific potential pathogenic genes and functional pathways in Alzheimer’s Disease
    Xiaolan Wang, Lianjian Li · 2021 · BMC Neurology
  41. A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies
    Daniela Jaime García, Audrey Chagnot, Joanna Marguerite Wardlaw, Axel Montagne · 2023 · International Journal of Molecular Sciences
  42. The blood-brain barrier, a key bridge to treat neurodegenerative diseases
    Zhongci Hang, Liping Zhou, Cencan Xing, Yongqiang Wen, Hongwu Du · 2023 · Ageing Research Reviews
  43. Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature
    Manon Leclerc, Cyntia Tremblay, Philippe Bourassa, Julie A. Schneider, David Alan Bennett, Frédéric Calon · 2024 · Journal of Cerebral Blood Flow & Metabolism
  44. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains
    Kee-Chan Ahn, Cameron R. Learman, Gary Leo Dunbar, Panchanan Maiti, Won‐Cheoul Jang, Hyeon Cheol, Mee-Sook Song · 2018 · Neuroscience
  45. Microphysiological systems for recapitulating physiology and function of blood-brain barrier
    Su‐Yeong Seo, Hwieun Kim, Jong Hwan Sung, Nakwon Choi, Kangwon Lee, Hong Nam Kim · 2019 · Biomaterials
  46. Alteration in the Function and Expression of SLC and ABC Transporters in the Neurovascular Unit in Alzheimer’s Disease and the Clinical Significance
    Yongming Jia, Na Wang, Yingbo Zhang, Di Xue, Haoming Lou, Xue‐Wei Liu · 2020 · Aging and Disease
  47. D-Glucose uptake and clearance in the tauopathy Alzheimer’s disease mouse brain detected by on-resonance variable delay multiple pulse MRI
    Lin Chen, Zhiliang Wei, Kannie W. Y. Chan, Yuguo Li, Kapil Suchal, Sheng Bi, Jianpan Huang, Xiang Xu, Philip C. Wong, Hanzhang Lu et al. · 2020 · Journal of Cerebral Blood Flow & Metabolism
  48. Regional cerebral hypometabolism on 18F‐FDG PET/CT scan in delirium is independent of acute illness and dementia
    Anita Nitchingham, Jarett Vanz‐Brian Pereira, Eva Alina Wegner, Vincent Oxenham, Jacqueline Close, Gideon A. Caplan · 2022 · Alzheimer s & Dementia
  49. Cellular senescence and the blood–brain barrier: Implications for aging and age-related diseases
    Rachel C. Knopp, Michelle A. Erickson, Elizabeth M. Rhea, May J. Reed, William A. Banks · 2023 · Experimental Biology and Medicine
  50. Recent Developments in Understanding Brain Aging: Implications for Alzheimer’s Disease and Vascular Cognitive Impairment
    Ferenc Deák, Willard M. Freeman, Zoltan I. Ungvari, Anna Csiszár, William Edmund Sonntag · 2015 · The Journals of Gerontology Series A
  51. Nurr1 Modulation Mediates Neuroprotective Effects of Statins
    Sabine Willems, Julian Aurelio Marschner, Whitney Kilu, Giuseppe Faudone, Romy Busch, Silke Duensing‐Kropp, Jan Heering, Daniel Merk · 2022 · Advanced Science
  52. Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice
    Shaoyu Zhou, Feng Jie Jin, Fei Yan, Ju Liu, Meixiang Chen, Ying Zhang, Sheng-Jiao Wei, Hai Dan Jin, Jing Nie, Xiao-Long Fu et al. · 2022 · Neural Regeneration Research
  53. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer’s disease
    Jana, Arundhati, Wang, Xinge, Leasure, Joseph W., Magana, Lissette, Wang, Li, Kim, Young-Mee, Dodiya, Hemraj, Toth, Peter T., Sisodia, Sangram S., Rehman, Jalees · 2022 · Scientific Reports
  54. Targeting Transferrin Receptor 1 for Enhancing Drug Delivery Through the Blood–Brain Barrier for Alzheimer’s Disease
    Xiaoxia Shen, Huan Li, Beiyu Zhang, Yunan Li, Zheying Zhu · 2025 · International Journal of Molecular Sciences
  55. Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells
    Karin Lauschke, Lise Frederiksen, Vanessa Jane Hall · 2017 · Stem Cells and Development
  56. Brain Endothelial Cells in Blood–Brain Barrier Regulation and Neurological Therapy
    Yuqing Xiang, Qiuxiang Gu, Dong Liu · 2025 · International Journal of Molecular Sciences
  57. Alzheimer’s Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis
    Edward R. Blonz · 2017 · Journal of Alzheimer s Disease
  58. The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer’s Disease Therapeutics and Diagnostics
    Cristina de la Torre, Valentı́n Ceña · 2018 · Pharmaceutics
  59. Lipid-Binding Proteins in Brain Health and Disease
    Miriam Corraliza-Gómez, Diego Sánchez, María Dolores Ganfornina · 2019 · Frontiers in Neurology
  60. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro
    Snehal Raut, Ronak Patel, Abraham Jacob Al-Ahmad · 2021 · Fluids and Barriers of the CNS
  61. Glut1 deficiency syndrome: New and emerging insights into a prototypical brain energy failure disorder
    Maoxue Tang, Umrao R. Monani · 2021 · Neuroscience Insights
  62. Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists
    Hussein N. Yassine, Victoria A. Solomon, Angad Thakral, Nasim Sheikh‐Bahaei, Helena Chang Chui, Meredith N. Braskie, Lon S. S. Schneider, Konrad Talbot · 2021 · Alzheimer s & Dementia
  63. Metformin in Alzheimer’s disease: An overview of potential mechanisms, preclinical and clinical findings
    Mohammad Rafi Khezri, Keyvan Yousefi, Negin Mahboubi, Darya Hodaei, Morteza Ghasemnejad‐Berenji · 2022 · Biochemical Pharmacology
  64. Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer’s Disease
    Austin M. Reilly, Andy Po‐Yi Tsai, Peter Bor‐Chian Lin, Aaron C. Ericsson, Adrian L. Oblak, Hongxia Ren · 2020 · Nutrients
  65. Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation
    Marine Tournissac, Manon Leclerc, Josue Valentin‐Escalera, Milène Vandal, Cristina R. Bosoi, Emmanuel Planel, Frédéric Calon · 2021 · Ageing Research Reviews
  66. Does hyperglycemia downregulate glucose transporters in the brain?
    Luana Lemos Leão, Gro Gujord Tangen, Maria Lage Barca, Knut Engedal, Sérgio Henrique Sousa Santos, Frederico Sander Mansur Machado, Alfredo Maurício Batista de Paula, Renato Sobral Monteiro-Júnior · 2020 · Medical Hypotheses
  67. Historical and current perspectives on blood endothelial cell heterogeneity in the brain
    Ryota L. Matsuoka, Luke D. Buck, Keerti P. Vajrala, Rachael E. Quick, Olivia A. Card · 2022 · Cellular and Molecular Life Sciences
  68. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
    Goran Šimić, Ena Španić, Lea Langer Horvat, Patrick R. Hof · 2019 · Progress in molecular biology and translational science
  69. An early endothelial cell–specific requirement for Glut1 is revealed in Glut1 deficiency syndrome model mice
    Maoxue Tang, Sarah H. Park, Sabrina Petri, Hang Yu, Carlos B. Rueda, E. Dale Abel, Carla Y. Kim, Elizabeth M. C. Hillman, Fanghua Li, Yeojin Lee et al. · 2020 · JCI Insight
  70. Endothelial Iron Homeostasis Regulates Blood-Brain Barrier Integrity via the HIF2α—Ve-Cadherin Pathway
    Daniel Rand, Orly Ravid, Dana Atrakchi, Hila Israelov, Yael Bresler, Chen Shemesh, Liora Omesi, Sigal Liraz Zaltsman, Fabien Gosselet, Taber S. Maskrey et al. · 2021 · Pharmaceutics
  71. cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer’s Disease
    Dolores Viña, Nuria Seoane, Elisardo C. Vasquez, Manuel Campos‐Toimil · 2021 · Cells
  72. Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders
    Callan D. McLoughlin, Sarah Nevins, Joshua B. Stein, Mehrdad Khakbiz, Ki‐Bum Lee · 2024 · Small Science
  73. Astrocytic GLUT1 deletion in adult mice enhances glucose metabolism and resilience to stroke
    Laetitia Thieren, Henri S. Zanker, Jeanne Droux, Urvashi Dalvi, Matthias Tasso Wyss, Rebecca Waag, Pierre‐Luc Germain, Lukas von Ziegler, Zoe J. Looser, Ladina Hösli et al. · 2025 · Nature Communications
  74. Comparative study of expression and activity of glucose transporters between stem cell-derived brain microvascular endothelial cells and hCMEC/D3 cells
    Abraham Jacob Al-Ahmad · 2017 · American Journal of Physiology-Cell Physiology
  75. Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications
    Anamaria Jurcău, Aurel Simion · 2020 · CNS & Neurological Disorders - Drug Targets
  76. Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders
    Ajay R. Uprety, Yeji Kang, Soo Young Kim · 2021 · Archives of Pharmacal Research
  77. Astrocytic microRNAs and transcription factors in Alzheimer’s disease and therapeutic interventions
    Nassar, Ajmal, Kodi, Triveni, Satarker, Sairaj, Chowdari Gurram, Prasada, Upadhya, Dinesh, SM, Fayaz, Mudgal, Jayesh, Nampoothiri, Madhavan · 2022 · Cells
  78. Epigenetic regulation of the glucose transporter geneSlc2a1by β‐hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice
    Kosuke Tanegashima, Yukiko Sato‐Miyata, Masabumi Funakoshi, Yasumasa Nishito, Toshiro Aigaki, Takahiko Hara · 2016 · Genes to Cells
  79. ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells
    Hu Zhang, Shuhong Zhang, Jilin Zhang, Dongxin Liu, Jiayi Wei, Wen‐Gang Fang, Wei‐Dong Zhao, Yuhua Chen, De‐Shu Shang · 2017 · Journal of Cerebral Blood Flow & Metabolism
  80. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells
    Jiyeon Lee, Haeryung Lee, Hyein G. Lee, Miram Shin, Min-Gi Shin, Jinsoo Seo, Eun Jeong Lee, Sun Ah Park, Soochul Park · 2023 · Nature Communications
  81. The Beneficial Role of Exercise on Treating Alzheimer’s Disease by Inhibiting β-Amyloid Peptide
    Zixuan Tan, Fang Dong, Linyu Wu, Ya-Shuo Feng, Feng Zhang · 2021 · Molecular Neurobiology
  82. Neural Metabolic Networks: Key Elements of Healthy Brain Function
    Nimrod Madrer, Nirma D. Perera, Nonthué Alejandra Uccelli, Alice Abbondanza, Jens Velde Andersen, Emma Veronica Carsana, Matthew D. Demmings, Regina F. Fernandez, Matheus Garcia de Fragas, Ismail Gbadamosi et al. · 2025 · Journal of Neurochemistry
  83. α-Lipoic Acid Maintains Brain Glucose Metabolism via BDNF/TrkB/HIF-1α Signaling Pathway in P301S Mice
    Yanhui Zhang, Xin-zhu Yan, Shuangfeng Xu, Zhongqiu Pang, Linbo Li, Yang Yang, Yonggang Fan, Zhuo Wang, Xin Yu, Chuang Guo et al. · 2020 · Frontiers in Aging Neuroscience
  84. Astrocytes as Neuroimmunocytes in Alzheimer’s Disease: A Biochemical Tool in the Neuron–Glia Crosstalk along the Pathogenetic Pathways
    Stefano Stanca, Martina Rossetti, Paolo Bongioanni · 2023 · International Journal of Molecular Sciences
  85. Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets
    Aparna Chauhan, Sachin Dubey, Smita Jain · 2024 · Cell Biochemistry and Function
  86. Intranasal cotinine improves memory, and reduces depressive-like behavior, and GFAP + cells loss induced by restraint stress in mice
    Nelson Perez-Urrutia, Cristhian Mendoza, Nathalie Alvarez-Ricartes, Patricia Oliveros-Matus, Florencia Echeverria, J. Alex Grizzell, George Emilio Barreto, Alexandre Iarkov, Valentina Echeverrı́a · 2017 · Experimental Neurology
  87. Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease
    Choy Ker Woon, Wong Kah Hui, Razif Abas, Muhammad Huzaimi Haron, Srijit Das, Teoh Seong Lin · 2021 · Current Neuropharmacology
  88. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer’s Disease Pathology in a Sex-Dependent Manner
    Sarah Lecordier, Vincent Pons, Serge Rivest, Ayman ElAli · 2022 · Frontiers in Immunology
  89. Inhibiting NLRP3 Inflammasome Activation by CY-09 Helps to Restore Cerebral Glucose Metabolism in 3×Tg-AD Mice
    Shuangxue Han, Zhijun He, Xia Hu, Xiaoqian Li, Kaixin Zheng, Yingying Huang, Peng Xiao, Qingguo Xie, Jiazuan Ni, Qiong Liu · 2023 · Antioxidants
  90. Risk factors, preventive interventions, overlapping symptoms, and clinical measures of delirium in elderly patients
    Xi Mei, Yuehong Liu, Ya-Qing Han, Chengying Zheng · 2023 · World Journal of Psychiatry
  91. The emerging role of brain neuroinflammatory responses in Alzheimer’s disease
    Mandana AmeliMojarad, Melika AmeliMojarad, Xiaonan Cui · 2024 · Frontiers in Aging Neuroscience
  92. Alzheimer amyloid-β- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood
    Hendrix, Rachel D., Ou, Yang, Davis, Jakeira E., Odle, Angela K., Groves, Thomas R., Allen, Antiño R., Childs, Gwen V., Barger, Steven W. · 2021 · Neurobiology of Aging
  93. Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy
    Yan Li, Linying Liu, Weihong Ji, Huang Peng, Ruichen Zhao, Xin Zhang · 2020 · Nano Today
  94. The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
    Susana Santos Correia, Guang Liu, Sarah Jacobson, Sylvie G. Bernier, Jenny V. Tobin, Chad D. Schwartzkopf, Emily Atwater, Elisabeth Lonie, Sam Rivers, Andrew Carvalho et al. · 2021 · Journal of Neuroinflammation
  95. Sugar and Alzheimer's disease: a bittersweet truth
    Costantino Iadecola · 2015 · Nature Neuroscience
  96. Interactions between nanoparticles and pathological changes of vascular in Alzheimer’s disease
    Ting Lei, Zixiao Yang, Hanmei Li, Meng Qin, Huile Gao · 2024 · Advanced Drug Delivery Reviews
  97. Senescence-associated microvascular endothelial dysfunction: A focus on the blood-brain and blood-retinal barriers
    Sung Young Kim, Jaejoung Cheon · 2024 · Ageing Research Reviews
  98. An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter
    Pavitra Kannan, Martin Schain, Warren W. Kretzschmar, Lora D. Weidner, Nicholas Mitsios, Balázs Zoltán Gulyás, Hans Blom, Michael M. Gottesman, Robert B. Innis, Matthew D. Hall et al. · 2016 · Journal of Cerebral Blood Flow & Metabolism
  99. G Protein-Coupled Receptors in the Mammalian Blood-Brain Barrier
    Brock R. Pluimer, Mark Colt, Zhen Zhao · 2020 · Frontiers in Cellular Neuroscience
  100. Senescence and associated blood–brain barrier alterations in vitro
    Ellaine Salvador, Małgorzata Burek, Mario Löhr, Michiaki Nagai, Carsten Hagemann, Carola Yvette Förster · 2021 · Histochemistry and Cell Biology